Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome
Trial details
- Registry ID
- NCT06527937
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Pharmacokinetics Study of DESF in Adults With Oral Allergy SyndromeNCT06527937 | Aquestive Therapeutics | Phase 2 | Completed | 2024-10-10Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |